A Second Class stamp http://planomassage.guru/zyprexa-5-mg-half-life-edb1.pdf olanzapine zyprexa package insert  ** PROSENSA, $7.93, down 67 pct (1:17 p.m. ET)  An experimental drug for Duchenne muscular dystrophy fromGlaxoSmithKline and Prosensa failed to meet its goal in alate-stage clinical trial, the companies said on Friday. Thedrug, drisapersen, did not show a statistically significantimprovement in the distance that patients could walk in sixminutes compared to a placebo in the Phase three test.